使用含有CyclinT1-Tat的病毒样颗粒选择性地激活潜伏HIV
Thomas K Lavin1, Caroline O Tabler2, Thomas J Sweet2
1Department of Pathology, Case Western Reserve University, Cleveland, OH, 44106, USA; Medical Scientist Training Program, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Virology
|January 14, 2026
概括
携带CyclinT1-Tat融合蛋白 (CycTat) 的新型病毒样颗粒 (VLPs) 能够有效地重新激活潜伏的HIV. 这种有针对性的方法显示出对艾滋病毒治疗策略的承诺,使用最小的T细胞激活.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 持续存在的艾滋病毒存储库阻止治愈,需要像"杀"这样的策略.
- 化学延迟逆转剂 (LRAs) 在效力,特异性和安全性方面存在局限性.
- 需要新的输送系统来增强艾滋病毒的活性和治疗效果.
研究的目的:
- 开发和描述基于HIV的新型病毒样颗粒 (VLPs),这些颗粒被设计为提供CyclinT1-Tat融合蛋白 (CycTat).
- 评估携带CycTat的VLPs在激活潜伏HIV的疗效,无论单独还是与化学LRA协同.
- 评估这些工程VLP的安全性和特异性,用于潜在的HIV治疗应用.
主要方法:
- 基于HIV的VLP的构建和表征,其中封装了一个CyclinT1-Tat融合蛋白 (CycTat).
- 在细胞模型中使用CycTat-VLPs,Tat和与化学LRAs (勃罗莫多胺抑制剂,PKC激动剂) 组合的细胞模型中评估HIV从潜伏期的活性化.
- 在高剂量的初级CD4+T细胞上使用CycTat-VLP的体外安全性评估.
主要成果:
- 在某些条件下,CycTat-VLPs表现出强大的HIV活性,在某些条件下表现优于单独的Tat.
- 当将CycTat-VLPs与测试化学物质LRAs结合时,观察到协同活性.
- 影响Tat-CycT1相互作用的向突变减少了活性化,证实了机制.
- 与目标细胞的VLP融合对于重新激活至关重要,这表明了特定的输送.
- 高剂量VLP的使用显示了初级CD4+T细胞的最小激活,这表明了有利的安全性.
结论:
- 携带CycTat的基于HIV的工程VLP代表了针对性HIV再激活的有希望的平台.
- 与单独的Tat相比,CycTat融合蛋白增强了HIV的重新激活.
- VLPs为延迟逆转疗法提供了特定的交付和改进的安全配置文件.
- 这种方法提供了一种概念验证,通过通过VLP提供向蛋白质来增强艾滋病毒治愈策略.
更多相关视频
12:22A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation
Published on: April 2, 2012
18.0K
14:27CRISPR-Cas9-based Genome Engineering to Generate Jurkat Reporter Models for HIV-1 Infection with Selected Proviral Integration Sites
Published on: November 14, 2018
10.3K
相关概念视频
Size and Structure of Viral Genomes
691
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
691
Retrovirus Life Cycles
49.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.3K
